Camps_2016_Chem.Biol.Interact_259_382

Reference

Title : Paraoxonases, mitochondrial dysfunction and non-communicable diseases - Camps_2016_Chem.Biol.Interact_259_382
Author(s) : Camps J , Garcia-Heredia A , Hernandez-Aguilera A , Joven J
Ref : Chemico-Biological Interactions , 259 :382 , 2016
Abstract :

The most common non-communicable diseases (NCD) are obesity, cardiovascular disease, diabetes, cancer, chronic respiratory diseases, and neurological diseases. Together, they constitute the commonest cause of death and disability worldwide. Mitochondrial alterations, oxidative stress and inflammation underpin NCD and are molecular mechanisms playing major roles in the disease onset and natural history. Interrelations between the mechanisms of oxidative stress, inflammation and metabolism are, in the broadest sense of energy transformations, being increasingly recognized as part of the problem in NCD. Whether or not oxidative stress and inflammation are the causes or the consequences of cellular disturbances, they do significantly contribute to NCD. Paraoxonases are associated with mitochondria and mitochondria-associated membranes. They modulate mitochondria-dependent superoxide production, and prevent apoptosis. Their overexpression protects mitochondria from endoplasmic reticulum stress and subsequent mitochondrial dysfunction; highlighting that the anti-inflammatory effects of paraoxonases may be mediated, at least in part, by their protective role in mitochondria and associated organelle function. Since oxidative stress is implicated in the development of NCD (as a result of mitochondrial dysfunction), these data suggest that understanding the role and the molecular targets of paraoxonases may provide novel strategies of intervention in the treatment of these important diseases.

PubMedSearch : Camps_2016_Chem.Biol.Interact_259_382
PubMedID: 27062890

Related information

Citations formats

Camps J, Garcia-Heredia A, Hernandez-Aguilera A, Joven J (2016)
Paraoxonases, mitochondrial dysfunction and non-communicable diseases
Chemico-Biological Interactions 259 :382

Camps J, Garcia-Heredia A, Hernandez-Aguilera A, Joven J (2016)
Chemico-Biological Interactions 259 :382